{"date":"2025-05-08","count":68,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4198-2025-05-08-1846-tulf6t","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"18:46:45","subject":"公告本公司董事會決議召開114年股東常會相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-05-08 18:46，「公告本公司董事會決議召開114年股東常會相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-05-08-1832-1iw3yxh","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"18:32:19","subject":"公告代子公司瑞亞生醫(股)公司總經理異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-05-08 18:32，「公告代子公司瑞亞生醫(股)公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-05-08-1832-bvfon7","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"18:32:02","subject":"本公司發言人及代理發言人異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-05-08 18:32，「本公司發言人及代理發言人異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-05-08-1831-ap4ctl","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"18:31:37","subject":"公告本公司董事會通過委任總經理","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-05-08 18:31，「公告本公司董事會通過委任總經理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-05-08-1830-tq97v6","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"18:30:59","subject":"公告本公司董事會決議辦理私募有價證券相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-05-08 18:30，「公告本公司董事會決議辦理私募有價證券相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-05-08-1829-rmlwjc","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"18:29:28","subject":"公告本公司不繼續辦理113年股東會通過之私募有價證券剩餘額度案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-05-08 18:29，「公告本公司不繼續辦理113年股東會通過之私募有價證券剩餘額度案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4198-2025-05-08-1828-1l0n9c0","company_id":"4198","company":"欣大健康","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"18:28:46","subject":"公告本公司董事會通過114年第1季合併財報務告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：欣大健康（4198），2025-05-08 18:28，「公告本公司董事會通過114年第1季合併財報務告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-05-08-1811-1j4f2tm","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"18:11:01","subject":"依公開發行公司資金貸與及背書保證處理準則第25條第1項第4款公告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-05-08 18:11，「依公開發行公司資金貸與及背書保證處理準則第25條第1項第4款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-05-08-1810-wr0tu2","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"18:10:48","subject":"公告本公司總經理異動","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-05-08 18:10，「公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4139-2025-05-08-1810-1hte6dj","company_id":"4139","company":"馬光-KY","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"18:10:23","subject":"公告本公司董事會通過114年第一季合併財務報告案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：馬光-KY（4139），2025-05-08 18:10，「公告本公司董事會通過114年第一季合併財務報告案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6662-2025-05-08-1808-11l9h6d","company_id":"6662","company":"樂斯科","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"18:08:22","subject":"公告本公司董事會決議通過114年第1季財務報告","clause":"第31款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：樂斯科（6662），2025-05-08 18:08，「公告本公司董事會決議通過114年第1季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-05-08-1744-1nb6xrz","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:44:08","subject":"代重要子公司優品生醫股份有限公司公告法人股東重新指派董事擔任董事長","clause":"第6款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-05-08 17:44，「代重要子公司優品生醫股份有限公司公告法人股東重新指派董事擔任董事長」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-05-08-1740-hcclaf","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:40:01","subject":"代重要子公司優品生醫股份有限公司公告決議盈餘分配案","clause":"第14款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-05-08 17:40，「代重要子公司優品生醫股份有限公司公告決議盈餘分配案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-05-08-1737-4yzujo","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:37:32","subject":"公告本公司訂定除息基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-05-08 17:37，「公告本公司訂定除息基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-05-08-1737-lxn1wg","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:37:04","subject":"依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第三款公告","clause":"第23款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-05-08 17:37，「依公開發行公司資金貸與及背書保證處理準則第二十二條第一項第二款及第三款公告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7713-2025-05-08-1732-9qofud","company_id":"7713","company":"威力德生醫","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:32:59","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：威力德生醫（7713），2025-05-08 17:32，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-05-08-1729-dta3eh","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:29:48","subject":"公告本公司董事會決議召開114年股東常會事宜(新增討論事宜)","clause":"第17款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-05-08 17:29，「公告本公司董事會決議召開114年股東常會事宜(新增討論事宜)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4155-2025-05-08-1727-1o641hk","company_id":"4155","company":"訊映","market":"上市","industry":"生技醫療","date":"2025-05-08","time":"17:27:49","subject":"本公司董事會通過114年第一季財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：訊映（4155），2025-05-08 17:27，「本公司董事會通過114年第一季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4192-2025-05-08-1716-9qofud","company_id":"4192","company":"杏國","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:16:09","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏國（4192），2025-05-08 17:16，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-05-08-1715-10lmqr3","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:15:09","subject":"公告本公司董事會決議得視金融市場狀況辦理私募有價證券","clause":"第11款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-05-08 17:15，「公告本公司董事會決議得視金融市場狀況辦理私募有價證券」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-05-08-1713-1yvi7ml","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:13:02","subject":"公告本公司董事會授權董事長訂定除權基準日相關事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-05-08 17:13，「公告本公司董事會授權董事長訂定除權基準日相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6712-2025-05-08-1712-wsqazv","company_id":"6712","company":"長聖","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:12:43","subject":"公告本公司董事會決議通過114年第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：長聖（6712），2025-05-08 17:12，「公告本公司董事會決議通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-05-08-1712-q2f7sg","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:12:36","subject":"公告本公司董事會決議113年股東常會通過之私募普通股案，尚餘額度之發行期限將屆滿，屆期則不予辦理","clause":"第16款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-05-08 17:12，「公告本公司董事會決議113年股東常會通過之私募普通股案，尚餘額度之發行期限將屆滿，屆期則不予辦理」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2025-05-08-1711-13bqai2","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:11:36","subject":"本公司董事會決議股利分派","clause":"第14款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2025-05-08 17:11，「本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-05-08-1710-1atlj5h","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:10:16","subject":"公告本公司董事會決議不繼續辦理113年股東常會通過之私募普通股案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-05-08 17:10，「公告本公司董事會決議不繼續辦理113年股東常會通過之私募普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1799-2025-05-08-1709-1oq17s0","company_id":"1799","company":"易威","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:09:58","subject":"公告本公司董事會通過114年第1季合併財務報告","clause":"第31款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：易威（1799），2025-05-08 17:09，「公告本公司董事會通過114年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6523-2025-05-08-1706-1oq17s0","company_id":"6523","company":"達爾膚","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:06:44","subject":"公告本公司董事會通過114年第1季合併財務報告","clause":"第31款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：達爾膚（6523），2025-05-08 17:06，「公告本公司董事會通過114年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-05-08-1706-rz65jz","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:06:39","subject":"公告本公司新增背書保證金額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款標準","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-05-08 17:06，「公告本公司新增背書保證金額達「公開發行公司資金貸與及背書保證處理準則」第二十五條第一項第四款標準」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-05-08-1703-e6zi91","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:03:37","subject":"公告本公司114年第1季合併財務報告經董事會決議通過","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-05-08 17:03，「公告本公司114年第1季合併財務報告經董事會決議通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4905-2025-05-08-1702-1oq17s0","company_id":"4905","company":"台聯電","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"17:02:58","subject":"公告本公司董事會通過114年第1季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台聯電（4905），2025-05-08 17:02，「公告本公司董事會通過114年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-05-08-1654-lg3qup","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"16:54:15","subject":"代子公司聲博科技股份有限公司公告董事會決議不分派113年度股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-05-08 16:54，「代子公司聲博科技股份有限公司公告董事會決議不分派113年度股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6892-2025-05-08-1649-2meytu","company_id":"6892","company":"台寶生醫","market":"興櫃","industry":"生技醫療","date":"2025-05-08","time":"16:49:29","subject":"本公司治療退化性關節炎異體間質幹細胞新藥Chondrochymal三期臨床試驗IND申請許可之申復進度更新","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：台寶生醫（6892），2025-05-08 16:49，「本公司治療退化性關節炎異體間質幹細胞新藥Chondrochymal三期臨床試驗IND申請許可之申復進度更新」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-05-08-1649-112rvmt","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"16:49:14","subject":"本公司向非關係人取得不動產","clause":"第20款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-05-08 16:49，「本公司向非關係人取得不動產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2025-05-08-1648-1md8tpl","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2025-05-08","time":"16:48:16","subject":"公告本公司董事會通過114年度員工認股權憑證發行及認股辦法","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2025-05-08 16:48，「公告本公司董事會通過114年度員工認股權憑證發行及認股辦法」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6586-2025-05-08-1647-7zhv4l","company_id":"6586","company":"醣基","market":"興櫃","industry":"生技醫療","date":"2025-05-08","time":"16:47:30","subject":"董事會決議114年度第1季不發放股利","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醣基（6586），2025-05-08 16:47，「董事會決議114年度第1季不發放股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-05-08-1639-hsrmut","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"16:39:20","subject":"代子公司聲博科技股份有限公司公告董事會決議召開民國114年實體股東常會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-05-08 16:39，「代子公司聲博科技股份有限公司公告董事會決議召開民國114年實體股東常會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4166-2025-05-08-1629-wsqazv","company_id":"4166","company":"友霖","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"16:29:55","subject":"公告本公司董事會決議通過114年第一季合併財務報告","clause":"第43款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：友霖（4166），2025-05-08 16:29，「公告本公司董事會決議通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2025-05-08-1618-17bus0f","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"16:18:23","subject":"公告本公司設置永續發展委員會","clause":"第6款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：精華（1565），2025-05-08 16:18，「公告本公司設置永續發展委員會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-05-08-1609-xpug3b","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"16:09:23","subject":"公告本公司董事會通過設置提名委員會及委任提名委員會委員","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-05-08 16:09，「公告本公司董事會通過設置提名委員會及委任提名委員會委員」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-05-08-1607-13xauvz","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-05-08","time":"16:07:01","subject":"公告本公司新增資金貸與金額達本公司最近期財務報表淨值百分之二以上","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-05-08 16:07，「公告本公司新增資金貸與金額達本公司最近期財務報表淨值百分之二以上」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-05-08-1604-8y3vwa","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-05-08","time":"16:04:50","subject":"公告本公司董事會決議通過新設立子公司","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-05-08 16:04，「公告本公司董事會決議通過新設立子公司」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-05-08-1603-16mw671","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-05-08","time":"16:03:53","subject":"公告本公司505(b)(2)新劑型新藥TAH3311抗血栓口溶膜之美國Pivotal study(樞紐試驗)取得最終臨床試驗報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-05-08 16:03，「公告本公司505(b)(2)新劑型新藥TAH3311抗血栓口溶膜之美國Pivotal study(樞紐試驗)取得最終臨床」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6876-2025-05-08-1603-1rpjgd9","company_id":"6876","company":"朗齊生醫*","market":"興櫃","industry":"生技醫療","date":"2025-05-08","time":"16:03:24","subject":"公告本公司董事會之議決事項，未經審計委員會通過，而經全體董事三分之二以上同意通過者","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：朗齊生醫*（6876），2025-05-08 16:03，「公告本公司董事會之議決事項，未經審計委員會通過，而經全體董事三分之二以上同意通過者」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4175-2025-05-08-1601-1bxfw8e","company_id":"4175","company":"杏一","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"16:01:59","subject":"公告本公司董事會提報民國114年第一季合併財務報表","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：杏一（4175），2025-05-08 16:01，「公告本公司董事會提報民國114年第一季合併財務報表」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-05-08-1601-whk8fh","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-05-08","time":"16:01:54","subject":"公告本公司國內第二次無擔保轉換公司債114年第1季轉換普通股之發行新股基準日","clause":"第11款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-05-08 16:01，「公告本公司國內第二次無擔保轉換公司債114年第1季轉換普通股之發行新股基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1786-2025-05-08-1600-9qofud","company_id":"1786","company":"科妍","market":"上市","industry":"生技醫療","date":"2025-05-08","time":"16:00:28","subject":"公告本公司董事會通過114年第一季合併財務報告","clause":"第31款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：科妍（1786），2025-05-08 16:00，「公告本公司董事會通過114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8409-2025-05-08-1551-30zqm5","company_id":"8409","company":"商之器","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"15:51:41","subject":"公告本公司經董事會決議之114年第一季合併財務報告","clause":"第31款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：商之器（8409），2025-05-08 15:51，「公告本公司經董事會決議之114年第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7832-2025-05-08-1549-19whda8","company_id":"7832","company":"智新生技*","market":"興櫃","industry":"生技醫療","date":"2025-05-08","time":"15:49:20","subject":"公告本公司興櫃掛牌股票每股面額新台幣1元","clause":"第44款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：智新生技*（7832），2025-05-08 15:49，「公告本公司興櫃掛牌股票每股面額新台幣1元」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2025-05-08-1547-17893oj","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"15:47:48","subject":"公告本公司董事會通過114年度第一季合併財務報告","clause":"第31款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2025-05-08 15:47，「公告本公司董事會通過114年度第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2025-05-08-1543-x3pjnm","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"15:43:56","subject":"本公司內部稽核主管異動","clause":"第8款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2025-05-08 15:43，「本公司內部稽核主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2025-05-08-1542-7lvi8z","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"15:42:30","subject":"本公司會計主管異動","clause":"第8款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2025-05-08 15:42，「本公司會計主管異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2025-05-08-1541-1qchk12","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"15:41:07","subject":"公告邦特生物科技(股)公司配發現金股利相關事宜","clause":"第14款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2025-05-08 15:41，「公告邦特生物科技(股)公司配發現金股利相關事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7799-2025-05-08-1540-q7tlc0","company_id":"7799","company":"禾榮科","market":"上市","industry":"生技醫療","date":"2025-05-08","time":"15:40:23","subject":"公告本公司取得會計師內部控制制度審查確信報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：禾榮科（7799），2025-05-08 15:40，「公告本公司取得會計師內部控制制度審查確信報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4147-2025-05-08-1539-1nwe8lq","company_id":"4147","company":"中裕","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"15:39:22","subject":"公告本公司內部人事異動","clause":"第8款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：中裕（4147），2025-05-08 15:39，「公告本公司內部人事異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4107-2025-05-08-1539-1y4k26b","company_id":"4107","company":"邦特","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"15:39:11","subject":"公告本公司民國114年度第1季合併財務報告","clause":"第31款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：邦特（4107），2025-05-08 15:39，「公告本公司民國114年度第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-8432-2025-05-08-1526-1oq17s0","company_id":"8432","company":"東生華","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"15:26:48","subject":"公告本公司董事會通過114年第1季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：東生華（8432），2025-05-08 15:26，「公告本公司董事會通過114年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-05-08-1519-wr0tu2","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"15:19:11","subject":"公告本公司總經理異動","clause":"第6款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-05-08 15:19，「公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3118-2025-05-08-1515-ojcdb1","company_id":"3118","company":"進階","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"15:15:05","subject":"公告本公司董事會通過114年度第1季財務報告","clause":"第31款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：進階（3118），2025-05-08 15:15，「公告本公司董事會通過114年度第1季財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-05-08-1507-329auq","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-05-08","time":"15:07:39","subject":"代子公司微碩（上海）日用品有限公司向關係人取得不動產使用權資產","clause":"第20款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-05-08 15:07，「代子公司微碩（上海）日用品有限公司向關係人取得不動產使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-05-08-1504-jsmo6t","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-05-08","time":"15:04:51","subject":"代子公司克麗緹娜（中國）貿易有限公司向關係人取得不動產使用權資產","clause":"第20款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-05-08 15:04，「代子公司克麗緹娜（中國）貿易有限公司向關係人取得不動產使用權資產」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-05-08-1502-481v7y","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-05-08","time":"15:02:49","subject":"公告本公司董事會決議通過114年第1季合併財務報告","clause":"第31款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-05-08 15:02，「公告本公司董事會決議通過114年第1季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4137-2025-05-08-1501-1egfkms","company_id":"4137","company":"麗豐-KY","market":"上市","industry":"生技醫療","date":"2025-05-08","time":"15:01:28","subject":"公告本公司董事會通過重要決議","clause":"第51款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：麗豐-KY（4137），2025-05-08 15:01，「公告本公司董事會通過重要決議」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1565-2025-05-08-1458-qc1716","company_id":"1565","company":"精華","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"14:58:13","subject":"公告本公司114年第1季合併財務報告業經董事會通過","clause":"第31款","fact_date":"2025-05-08","cite_as":"公開資訊觀測站重大訊息：精華（1565），2025-05-08 14:58，「公告本公司114年第1季合併財務報告業經董事會通過」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6598-2025-05-08-1438-17893oj","company_id":"6598","company":"ABC-KY","market":"上市","industry":"生技醫療","date":"2025-05-08","time":"14:38:48","subject":"公告本公司董事會通過114年度第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：ABC-KY（6598），2025-05-08 14:38，「公告本公司董事會通過114年度第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6785-2025-05-08-1413-qwnt8m","company_id":"6785","company":"昱展新藥","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"14:13:53","subject":"公告本公司董事會通過114年第一季度個別財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：昱展新藥（6785），2025-05-08 14:13，「公告本公司董事會通過114年第一季度個別財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2025-05-08-1345-gngn95","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"13:45:16","subject":"本公司董事會決議訂定註銷限制員工權利新股減資基準日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2025-05-08 13:45，「本公司董事會決議訂定註銷限制員工權利新股減資基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4168-2025-05-08-1344-17893oj","company_id":"4168","company":"醣聯","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"13:44:02","subject":"公告本公司董事會通過114年度第一季合併財務報告","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：醣聯（4168），2025-05-08 13:44，「公告本公司董事會通過114年度第一季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6499-2025-05-08-0233-u0hjoc","company_id":"6499","company":"益安","market":"上櫃","industry":"生技醫療","date":"2025-05-08","time":"02:33:36","subject":"公告攝護腺微創治療醫材Urocross在美執行Expander-2樞紐臨床試驗初步結果","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：益安（6499），2025-05-08 02:33，「公告攝護腺微創治療醫材Urocross在美執行Expander-2樞紐臨床試驗初步結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}